DEVELOPMENT OF A RISK ASSESSMENT TOOL TO DETERMINE WHETHER PATIENTS WITH GHB/GBL DEPENDENCE CAN BE MANAGED IN AN OUT-PATIENT OR IN-PATIENT SETTING. Bowden-Jones O 1 , Dargan PI 2 , Lingford-Hughes A 1 , Reed L 1 , Wood DM 2.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
DEVELOPMENT OF A RISK ASSESSMENT TOOL TO DETERMINE WHETHER PATIENTS WITH GHB/GBL DEPENDENCE CAN BE MANAGED IN AN OUT-PATIENT OR IN-PATIENT SETTING.
Bowden-Jones O1, Dargan PI2, Lingford-Hughes A1, Reed L1, Wood DM2
1Club Drug Clinic, Chelsea and Westminster Hospital, Central North West London NHS Foundation Trust, London, UK
2Clinical Toxicology Service, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK
i) current other recreational/illicit drug use;
ii) previous GHB/GBL withdrawal history;
iii) current level of social support;
iv) previous psychiatric history;
v) past medical history;
vi) intensity of GHB/GBL use.
i) dependent alcohol / benzodiazepine use;
ii) severe previous withdrawal and/or previous ICU admission for withdrawal therapy;
iii) lives alone/poor social support;
iv) psychosis / recent self-harm;
v) previous seizures/epilepsy;
vi) frequent daily dosing over an extended period.
The tool has subsequently been prospectively used in a small number of clinical assessments and has proven valuable in both acute hospital and community settings.